Research Paper Volume 15, Issue 12 pp 5673—5697

DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma

class="figure-viewer-img"

Figure 2. Clinical correlation analysis of DUSP10 in TCGA. (A) Association between DUSP10 expression and clinical traits of LGG in TCGA. (B) Variance analysis of DUSP10 expression in different clinical features (including age, gender, grade, and 1p/19q, IDH, and MGMT statuses) in the TCGA dataset. (C) Prognostic analysis of high-DUSP10 and low-DUSP10 subtypes in the TCGA dataset. (D) Distribution of risk score, OS, and OS status of high-DUSP10 and low-DUSP10 subtypes in the TCGA dataset. (E) Different proportions of the living situation between the two subtypes. (F) ROC curves representing the predictive role of the risk score in TCGA. (G, H) Univariate and multivariate Cox analyses of DUSP10 expression and clinicopathological characteristics in TCGA. *P < 0.05, **P < 0.01, ***P < 0.001.